MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Nocturnal Bradykinesia is better detected using wearable sensors in Parkinson’s disease compared to clinical outcome

    I. Murasan, M. Qamar, K. Poplawska-Domaszewicz, D. Trivedi, K R. Chaudhuri, C. Falup-Pecurariu (Brasov, Romania)

    Objective: To evaluate the range and motor state during sleep of PD patients by using subjective scale-based assessment as well as PKG.  To evaluate the…
  • 2024 International Congress

    Patients with Parkinson’s disease have frequently pincer nail deformity

    M. Sakamoto, H. Nagayama, K. Kimura (Tokyo, Japan)

    Objective: The purpose of this study is to investigate whether the patients with Parkinson's disease have frequently pincer nail deformity (PND). Background: In our routine…
  • 2024 International Congress

    Gender-related Cognitive Disparities in Hispanic Patients with Parkinson’s Disease: A Cross-Sectional Study

    D. Piana-Castillo, C. Rodriguez-Alarcon, G. Faggioni-Sanchez, D. Bustamante-Mieles, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)

    Objective: Investigate potential gender-based cognitive performance disparities within the Hispanic population diagnosed with Parkinson's disease (PD). Background: PD significantly impairs cognitive functions, adversely affecting the…
  • 2024 International Congress

    Two unusual cases of dopamine dysregulation syndrome in patients with Parkinson’s disease

    L. Lachance, P. Huot (Montreal, Canada)

    Objective: To present two cases of dopamine dysregulation syndrome (DDS) in patients with Parkinson’s disease (PD) who took extreme measures to access more dopaminergic medication.…
  • 2024 International Congress

    GPR30 agonists attenuate haloperidol-induced neurotoxicity in SH-SY5Y cells and adult zebrafish.

    SHU. Upadhayay, PKB. Kumar (Baathinda, India)

    Objective: Objective:1. To investigate the neuroprotective effect of FDA-approved compounds (Raloxifene and Fulvestrant) against haloperidol-induced neurotoxicity in SHSY-5Y cells and adult zebrafish2. To explore the molecular…
  • 2024 International Congress

    Oro-facial Dyskinesia and akathisia following Treatment by Olanzapine

    S. Saaf, S. Lhassani, Z. El Yacoubi, Y. Mimouni, M. El Azhari, L. Kazzoul, J. Aasfara, H. Ouhabi, A. Hazim (Casablanca, Morocco)

    Objective: To report the case of a pharmaco-induced oro-facial dyskinesia and akathisia. Background: Dyskinesia is a hyperkinetic, disorganized, involuntary movement disorder that can either be…
  • 2024 International Congress

    Parkinson’s Disease Burden in Underserved Populations Across the US in 2022

    S. Kowal, K. Rosettie, E. Mearns, N. Win, H. Lin, B. Musch (South San Francisco, USA)

    Objective: To examine disparities in Parkinson’s disease (PD) burden by race or ethnicity, age, sex and region in the US. Background: PD is the second…
  • 2024 International Congress

    Trend-Analysis of Movement Disorders, Malignant Neoplasms and Mortality from 1999-2020

    M. Ammar-Ur-Rahman, L. Munir, A. Khalid, A. Chaudhary (Lahore, Pakistan)

    Objective: We aimed to analyse the mortality and prevalence of Movement Disorders and Malignant Neoplasms from 1999-2020 in the United States to compare disparities among…
  • 2024 International Congress

    Validation of the Kazakh Version of the Movement Disorder Society-Unified Dyskinesia Rating Scale.

    S. Abdraimova, ZH. Myrzayev, A. Karimova, A. Talgatkyzy, T. Khaibullin, G. Kaishibayeva, S. Elubaeva, K. Esembekova, D. Choi, P. Martinez-Martin, C. Goetz, G. Stebbins, SH. Luo, CH. Shashkin, N. Zharkinbekova, R. Kaiyrzhanov (Shymkent, Kazakhstan)

    Objective: This study aimed to validate the Kazakh version of the Movement Disorder Society-Unified Dyskinesia Rating Scale Background: The Unified Dyskinesia Rating Scale (UDysRS) has…
  • 2024 International Congress

    Intelligent Assessment of Abnormal Movements in Neurological Disorders: An Update

    YJ. Bao, RH. Hong, WT. Qin, Z. Wu, YP. Song, LJ. Jin (Shanghai, China)

    Objective: Many neurological disorders often lead to various abnormal movements. Traditional assessment methods fail to accurately and objectively evaluate the affected muscles and the functional…
  • « Previous Page
  • 1
  • …
  • 114
  • 115
  • 116
  • 117
  • 118
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley